City Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 20.71 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.03B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

City Therapeutics, Inc. operates as a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines by engineering RNAi trigger molecules. The company develops RNAi-based medicines using engineered small interfering RNAs (siRNAs) and is building a pipeline of therapeutics targeting diseases across multiple therapeutic areas, including ophthalmologic conditions such as retinal diseases and geographic atrophy. It designs and engineers RNAi trigger molecules, such as smaller size, novel cleavage mechanisms, and tailored t...